Page last updated: 2024-10-28

hydroxyurea and Cyanosis

hydroxyurea has been researched along with Cyanosis in 1 studies

Cyanosis: A bluish or purplish discoloration of the skin and mucous membranes due to an increase in the amount of deoxygenated hemoglobin in the blood or a structural defect in the hemoglobin molecule.

Research Excerpts

ExcerptRelevanceReference
" MCV and HbF were higher among patients receiving HU, the increase in MCV being cumulative with HU dosage but the rise in HbF dose independent."1.29Fetal haemoglobin variations following hydroxyurea treatment in patients with cyanotic congenital heart disease. ( Casadevall, N; Deschamps, A; Ducrocq, R; Dunda, O; Elion, J; Girot, R; Krishnamoorty, R; Labie, D; Maier-Redelsperger, M; Triadou, P, 1994)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Triadou, P1
Maier-Redelsperger, M1
Krishnamoorty, R1
Deschamps, A1
Casadevall, N1
Dunda, O1
Ducrocq, R1
Elion, J1
Girot, R1
Labie, D1

Other Studies

1 other study available for hydroxyurea and Cyanosis

ArticleYear
Fetal haemoglobin variations following hydroxyurea treatment in patients with cyanotic congenital heart disease.
    Nouvelle revue francaise d'hematologie, 1994, Volume: 36, Issue:5

    Topics: Adolescent; Adult; Child; Cyanosis; Erythroid Precursor Cells; Erythropoietin; Female; Fetal Hemoglo

1994